Prolonged Response of a Patient with Relapsed Acute Myeloid Leukemia to a Novel Oral Bromodomain Extraterminal Inhibitor (BETi)

Acute myeloid leukemia (AML) is an aggressive clonal bone marrow cancer characterized by high rates of relapse and mortality. A middle-aged woman with AML relapsed twice after achieving complete remission with induction therapy and subsequent salvage therapy. She was then enrolled in a clinical tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang Muñoz, Meilen, Murphy, Jennifer A., Wolff, Johannes E., Jonas, Brian A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758129/
https://www.ncbi.nlm.nih.gov/pubmed/33381331
http://dx.doi.org/10.1155/2020/8830123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758129/
https://www.ncbi.nlm.nih.gov/pubmed/33381331
http://dx.doi.org/10.1155/2020/8830123

Ejemplares similares